New research has detected the presence of paraben esters in 99 percent of breast cancer tissues sampled.
The study examined 40 women who were being treated for primary breast cancer.
In 60 percent of cases, five of the different esters were present.
Jerilynn Prior MD and Susan Baxter PhD Unveil ‘The Estrogen Errors’
April 20, 2012 By Leave a Comment
In this revealing work, a medical writer and an internationally-known physician team up to explain the controversy over medicine prescribing estrogen for perimenopausal women in North America, and to detail why progesterone is actually a far more effective, and a far less risk-ridden, approach.
Breast Cancer Risk Increases with Estrogen HRT
March 19, 2012 By Leave a Comment
According to a study published March 15 in the Journal of the National Cancer Institute, thoughts about how estrogen alone or estrogen in addition to progestin influence the risk of developing breast cancer has considerably changed in the past 10 years due to results from the Women’s Health Initiative (WHI) randomized placebo-controlled hormone therapy trials, and from large prospective cohort studies.
Anti-estrogen therapy associated with reduced melanoma risk in women with breast cancer
January 29, 2012 By Leave a Comment
HemOnc Today Posted on HemOncToday.com January 5, 2012 Women with breast cancer undergoing anti-estrogen treatment may have a lower risk for melanoma, according to researchers from Switzerland and France. Previous research has demonstrated that higher estrogen levels may be associated with melanoma etiology, suggesting that anti-estrogen use should be linked to a decreased risk Continue Reading …
NIH Study shows caffeine consumption linked to estrogen changes
January 29, 2012 By Leave a Comment
For Immediate Release Thursday, January 26, 2012 Contact: Robert Bock or John McGrath 301-496-5133 Moderate caffeine intake associated with higher level for Asians, lower for whites Asian women who consumed an average of 200 milligrams or more of caffeine a day — the equivalent of roughly two cups of coffee — had Continue Reading …
Study shows estrogen works in the brain to keep weight in check
January 29, 2012 By Leave a Comment
Southwestern Medical Center DALLAS – Oct. 20, 2011 – A recent UT Southwestern Medical Center study found that estrogen regulates energy expenditure, appetite and body weight, while insufficient estrogen receptors in specific parts of the brain may lead to obesity. “Estrogen has a profound effect on metabolism,” said Dr. Deborah Clegg, associate professor of Continue Reading …
Thousands of women at risk from DES
January 23, 2012 By Leave a Comment
The Independent Thousands of women at risk from ‘silent Thalidomide’ A drug intended to prevent miscarriage is blamed for causing cancer in the daughters – and possibly even granddaughters – of women who took it decades ago. By Sarah Morrison and Jaymi McCann Sunday, January 22, 2012 Tens of thousands of British families are to Continue Reading …
Boston lawsuit claims DES-breast cancer link
January 11, 2012 By Leave a Comment
Yahoo Finance Boston lawsuit claims link between anti-miscarriage drug and breast cancer in daughters By Denise Lavoie, AP Legal Affairs Writer January 10, 2012 BOSTON (AP) — Arline MacCormack first heard about DES from her mother when she was 17. Three decades later, MacCormack believes that the drug her mother took to prevent miscarriages caused Continue Reading …
A True Help for the Cervical Dysplasia
January 6, 2012 By Leave a Comment
Pap101.com Natural Hormone Treatment of Cervical Dysplasia by Elizabeth Smith MD Previously, scientists had thought that cervical cancer was linked to sexual promiscuity and/or certain varieties of Human Papilloma Virus (HPV). Now, researchers believe that birth control pills are causing cervical cancer. Cervical dysplasia, is abnormal cells found on the cervix. If the cervical dysplasia Continue Reading …
Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol (DES)
October 8, 2011 By Leave a Comment
New England Journal of Medicine
N Engl J Med 2011; 365:1304-1314October 6, 2011
Background
Before 1971, several million women were exposed in utero to diethylstilbestrol (DES) given to their mothers to prevent pregnancy complications. Several adverse outcomes have been linked to such exposure, but their cumulative effects are not well understood.
Follow Us!